Semaglutide is gaining traction as a novel treatment for type 2 diabetes. This engineered glucagon-like peptide-1 (GLP-1) receptor agonist acts upon stimulating the pancreas to release more insulin and suppressing https://keiranuypj113401.wssblogs.com/35628248/understanding-semaglutide-a-comprehensive-guide